483 Linhai Tianyu Pharmaceutical Apr 2019

483 Linhai Tianyu Pharmaceutical Apr 2019

Joel Hustedt FDA, Teresa Navas FDA$119.00 - Available Now

FDA investigators audited the Linhai Tianyu Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 19 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Apr 2019
  • Location: Taizhou, China
  • FEI: 3013345425
Add To Cart